Publication Type : Journal Article
Publisher : Research Journal of Pharmacy and Technology
Source : Research Journal of Pharmacy and Technology, 2021, 14(9), pp. 4983-4986, DOI: 10.52711/0974-360X.2021.00867
Url : https://rjptonline.org/AbstractView.aspx?PID=2021-14-9-81
Keywords : Fungal diseases, Ketoconazole, Biovia Discovery studio, Benzimidazole, Molecular docking studies.
Campus : Kochi
School : School of Pharmacy
Department : Pharmaceutical Chemistry & Analysis
Year : 2021
Abstract : Fungus is a kind of living organism and yeast mould and mushrooms are types of fungi. The fungal infections are caused by the fungus. A fungus that invades the tissue can cause a disease that confined to the skin, spread into tissue, bone and organs or affect the whole body. Benzimidazole is a class of heterocyclic aromatic organic compound which posses pharmacological activities including antifungal, antitumor, antiparasitic, analgesic etc. Insilico methods can be used to identify target molecules using bioinformatics tool. The aim of our study was to conduct the insilico drug designing of some benzimidazole derivatives having antifungal activities. In our study the insilico drug design was performed using Biovia discovery studio.
Cite this Research Publication : Muralikrishnan, A., Nair, R.R., Banu, J.Pappachen, D.L.K. In silico designing of some benzimidazole derivatives for anti-fungal activity Research Journal of Pharmacy and Technology 2021, 14(9), pp. 4983-4986, DOI: 10.52711/0974-360X.2021.00867